Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy.

Saved in:
Bibliographic Details
Title: Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy.
Authors: Lauret Marie Joseph E; INSERM, UMR1098, RIGHT, Université de Bourgogne Franche-Comté, Besançon, France., Kirilovsky A; Immunology and Cancer Department, Laboratory of Integrative Cancer Immunology, Cordeliers Research Center, INSERM UMRS1138, Paris, France.; Faculté de Santé, Université de Paris, Paris, France., Lecoester B; INSERM, UMR1098, RIGHT, Université de Bourgogne Franche-Comté, Besançon, France., El Sissy C; Immunology and Cancer Department, Laboratory of Integrative Cancer Immunology, Cordeliers Research Center, INSERM UMRS1138, Paris, France.; Faculté de Santé, Université de Paris, Paris, France., Boullerot L; INSERM, UMR1098, RIGHT, Université de Bourgogne Franche-Comté, Besançon, France., Rangan L; INSERM, UMR1098, RIGHT, Université de Bourgogne Franche-Comté, Besançon, France., Marguier A; INSERM, UMR1098, RIGHT, Université de Bourgogne Franche-Comté, Besançon, France., Tochet F; Department of Radiation Oncology, CHU Besançon, Besançon, France., Dosset M; INSERM, UMR1098, RIGHT, Université de Bourgogne Franche-Comté, Besançon, France., Boustani J; INSERM, UMR1098, RIGHT, Université de Bourgogne Franche-Comté, Besançon, France.; Department of Radiation Oncology, CHU Besançon, Besançon, France., Ravel P; Equipe Bioinformatique et Biologie des Systèmes du Cancer, Institut de Recherche en Cancérologie de Montpellier-INSERM U1194, Montpellier, France., Boidot R; Department of Biology and Pathology of Tumors, Georges-François Leclerc Cancer Center, Dijon, France., Spehner L; INSERM, UMR1098, RIGHT, Université de Bourgogne Franche-Comté, Besançon, France., Haicheur-Adjouri N; Immunology and Cancer Department, Laboratory of Integrative Cancer Immunology, Cordeliers Research Center, INSERM UMRS1138, Paris, France.; Faculté de Santé, Université de Paris, Paris, France., Marliot F; Immunology and Cancer Department, Laboratory of Integrative Cancer Immunology, Cordeliers Research Center, INSERM UMRS1138, Paris, France.; Faculté de Santé, Université de Paris, Paris, France., Pallandre JR; INSERM, UMR1098, RIGHT, Université de Bourgogne Franche-Comté, Besançon, France., Bonnefoy F; INSERM, UMR1098, RIGHT, Université de Bourgogne Franche-Comté, Besançon, France., Scripcariu V; Department of Surgical Oncology, Regional Institute of Oncology Iaşi, Iasi, Romania., Van den Eynde M; Cliniques universitaires Saint-Luc Institut Roi Albert II, Bruxelles, Belgium., Cornillot E; Cancer Bioinformatics and Systems Biology, IRCM, Montpellier, France.; Faculté de Pharmacie, Université de Montpellier, Montpellier, France., Mirjolet C; Department of Radiation Oncology, Georges-Francois Leclerc Cancer Center, Dijon, France.; INSERM UMR 1231, Dijon, France., Pages F; Immunology and Cancer Department, Laboratory of Integrative Cancer Immunology, Cordeliers Research Center, INSERM UMRS1138, Paris, France.; Faculté de Santé, Université de Paris, Paris, France., Adotevi O; INSERM, UMR1098, RIGHT, Université de Bourgogne Franche-Comté, Besançon, France olivier.adotevi@univ-fcomte.fr.; Department of Medical Oncology, CHU Besançon, Besançon, France.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Jul; Vol. 9 (7).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2051-1426
DOI:10.1136/jitc-2020-002256